
The STI Clinical Update Series is a two, 1/2-day didactic course which provides registered participants with training in the most recent advancements in epidemiology, diagnosis, and management of viral and bacterial STIs. Clinicians from any states are welcome to attend. CME/CNE is offered for this class.
Livestream Webinar
Date: March 24-25, 2026
9:00 am - 1:00 pm Pacific Time
Cost: FREE
Pre-enrollment by March 20, 2026 is required.
Please Note: If you are registering a large group of participants or you are registering for someone other than yourself please contact uwptc@uw.edu for details on how to register. Thank you!
Learning Objectives
After completing this course, the learner will be able to:
1. Describe the current diagnostic procedures for sexually transmitted infections.
2. List the current recommended management, including prevention techniques, for STI infections.
3. Identify the relevant changes in the Centers for Disease Control and Prevention’s (CDC) Sexually Transmitted Infection Treatment Guidelines, 2021
TOPICS/PRESENTERS INCLUDE (subject to change):
Syphilis Update Epidemiology & Treatment-Raaka Kumbhakar, MD- no disclosures
HSV Update- Christine Johnston, MD, MPH (disclosures listed below)
Chlamydia Update- Hillary Liss, MD- no disclosures
Gonorrhea Update- Hillary Liss, MD- no disclosures
Sexual History Taking & Assessment- Abby Fessler, MD-no disclosures
Disclosure: In compliance with continuing education requirements, all planners and presenters/moderators must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use. CDC, our planners, and presenters/moderators wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Christine Johnston and she wishes to disclose the following ongoing relationships,
GSK- consultant and contracted grant research (ended)
Moderna- contracted grant researcher (ended)
Pfizer- consultant (ended), grant research support (ongoing)
Assembly Biosciences-consultant (ongoing), grant research support (ongoing)
AiCuris- consultant (ongoing)
Oxymo- consultant (ongoing)
Simplexia- consultant (ongoing)
All of the relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
The Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate based on race, color, national origin, age, disability, religion, or sex. To learn more visit: https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html.
UW PTC Planning Committee
UW PTC Medical Director (planning committee chair)-Christine Johnston, MD, MPH
Disclosure: In compliance with continuing education requirements, all planners and presenters/moderators must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use. CDC, our planners, and presenters/moderators wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Christine Johnston and she wishes to disclose the following ongoing relationships,
GSK- consultant and contracted grant research (ended)
Moderna- contracted grant researcher (ended)
Pfizer- consultant (ended), grant research support (ongoing)
Assembly Biosciences-consultant (ongoing), grant research support (ongoing)
AiCuris- consultant (ongoing)
Oxymo- consultant (ongoing)
Simplexia- consultant (ongoing)
All of the relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
The Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate based on race, color, national origin, age, disability, religion, or sex. To learn more visit: https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html.
UW PTC Program Director (planning committee member)-Amy Radford, MSW-no disclosures
After registering online, you will receive an email - at least one week before the course - with complete course details including instructions for accessing the webpage associated with this course.
Continuing Medical & Nursing Education Credit
FACULTY & PLANNING COMMITTEE DISCLOSURES:
It is the policy of the University of Washington and the UW Prevention Training Center, that the faculty, and planning committee, disclose real and apparent conflicts of interest relating to the topics in this educational activity. The UW Prevention Training Center has established policies that identify and resolve all conflicts of interest prior to the live presentation of this activity. For faculty and team information please visit: https://www.uwptc.org/ptcteam
CONTINUING MEDICAL EDUCATION:
The University of Washington is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CONTINUING NURSING EDUCATION:
ACCREDITATION STATEMENT
|

|
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
CNE: The Centers for Disease Control and Prevention designates this activity for 7 nursing contact hours.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters/moderators must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters/moderators wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Christine Johnston and Stephanie McLaughlin, they wish to disclose,
Christine Johnston's Disclosures
GSK- consultant and contracted grant research (ended)
Moderna- contracted grant researcher (ended)
Pfizer- consultant (ended), grant research support (ongoing)
Assembly Biosciences-consultant (ongoing), grant research support (ongoing)
AiCuris- consultant (ongoing)
Oxymo- consultant (ongoing)
Simplexia- consultant (ongoing)
All of the relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
The Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate based on race, color, national origin, age, disability, religion, or sex. To learn more visit: https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html.
Jessica Johnson
uwptc@uw.edu